Copenhagen, Denmark, 7–8 March 2017. Meeting report
DHS Analytical Studies No. 39
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...n these settings is often not known or substandard. Closing these gaps and ensuring patient-centred care imply that quality-assured and affordable TB services must be made available wherever people choose to seek care.
more
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...10. The financial statements report all the Organization’s revenue and expenses. The Organization’s operations are managed under three fund groups: (1) the General Fund, which supports the programme budget, (2) Member States – other, and (3) the Fiduciary Fund (Note 2.18 gives particulars of each of the funds). This segregation of resources facilitates clearer reporting of WHO’s revenues and expenses.
more
DHS Further Analysis Reports No. 88 - This further analysis examines levels, trends, and determinants of neonatal mortality in Rwanda, using data from the 2000, 2005, and 2010 Rwanda Demographic and Health Surveys (RDHS).
This book contains the findings of technical reviews of eight transitional shelter designs. It is divided into sections:
- Section A discusses transitional shelter design briefs, includes a programming checklist and explains how the shelters in this book were reviewed.
- Section B contains... summary findings of the technical reviews for the eight shelters.
- Section C contains design details for foundations, walls and roofs.
- Annexes contain details of materials, a template design brief, conversion tables, a glossary, and references.
more
"This Code provides practical guidance on how to manage health and safety risks associated with hazardous
chemicals for persons conducting a business or undertaking who use chemicals in their workplace."
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...ing this progress, countries have adopted the Every Newborn Tracking Tool. This report presents a compilation of the data collated by the Every Newborn Tracking Tool in 2016, when 51 countries adopted the tool; it also spotlights examples of specific country activity for each National Milestone. Finally, Global Milestones for 2020 were part of the Every Newborn Action Plan to guide global and regional work in support of country efforts and this report highlights relevant progress towards those Global Milestones.
more
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b158 (Published 05 February 2009)
Cite this as: BMJ 2009;338:b158
Correspondence to: A Burns alistair.burns@manchester.ac.uk
African Population Studies, Etude de la population africaine vol. 20 n° 2
La sexualité des adolescents est devenue un sujet de préoccupation de santé publique, avec l’extension du SIDA au cours de ces dernières années, particulièrement en milieu urbain.
Quels sont les déterminants des pr...atiques sexuelles des adolescents ? Pourquoi certaines
pratiques peuvent-elles être qualifiées de comportements à risque ? Dans quelles mesures les politiques de santé publique pourront-elles résoudre les problèmes liés à ces pratiques
sexuelles ? C’est pour apporter des éléments de réponse à ces questions que l’enquête sur le comportement sexuel a été menée auprès de 806 adolescents filles et garçons dans la ville de Bangui. Huit discussions de groupes ont été également organisées avec ces adolescents et leurs parents.
more
Rwanda Guidelines for variation to registered pharmaceutical products.